Merck & Co. (NYSE:MRK): Closing price $43.46
Merck’s Oxytrol for Women, the first over-the-counter treatment for overactive bladder in women ages 18 years and older, has been cleared by the FDA. The medication will remain available for men with overactive bladder by prescription only.
Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!